诱导的光热热化用于协同瘤治疗
Kun Chen1, Rui Sun2, Yudong Guan3
1NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
概括
这项研究引入了介导的有机纳米药物 (MMONs) 来克服瘤中的物理和化学障碍,增强光热-铁化疗法,以改善癌症治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 纳米医学是一种纳米医学.
- 癌症治疗 癌症治疗
背景情况:
- 纳米药物显示出与铁亡相关的癌症治疗的希望,但面临着瘤物理化学障碍的挑战.
- 瘤的物理障碍 (纤维质矩阵,高间位压) 和化学障碍 (氨酸丰富) 限制了纳米医药的输送和有效性.
- 脂质活性氧物种 (ROS) 的有效性受到这些障碍的破坏,阻碍了ferroptosis的诱导.
研究的目的:
- 开发一种以为媒介的有机基纳米药物 (MMONs),以克服瘤的物理化学障碍.
- 通过解决物理和化学瘤防御,增强协同光热-热治疗.
- 研究MMON在克服瘤微环境障碍方面的有效性背后的机制.
主要方法:
- 以二氧化 (MnO2) 为形状变形和软度转换而设计的基于有机的纳米医药 (MMONs).
- 评估MMON克服物理障碍的能力:细胞内化,瘤积累和药物透.
- 评估MMONs克服化学障碍的能力:谷氨清除和ROS生成.
- 在体外和体内研究,以证明协同效应的光热-热治疗.
- 对比蛋白质组分析以确定分子变化,包括线粒体反应.
主要成果:
- 通过MnO2介导的形状转换,MMONs有效地克服了物理瘤障碍,改善了细胞吸收和瘤透.
- MMONs通过双重GSH清除和增强的ROS生产来证明强大的化学障碍克服.
- 通过克服物理和化学障碍,协同光热-热治疗显著增强.
- 蛋白质组分析揭示了铁亡促进和短暂的线粒体抑制反应.
结论:
- 在基于纳米医学的癌症治疗中,MMONs代表了克服瘤物理化学障碍的新策略.
- 介导的方法增强了协同光热-铁化治疗的疗效.
- 这种纳米医药设计为改善针对复杂瘤防御的癌症治疗策略提供了有希望的途径.
更多相关视频
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
2.3K
04:01Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
932
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...